Kalyan Bio-Medical Waste Management Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-06-2024
- Paid Up Capital ₹ 0.10 M
as on 21-06-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Kalyan Bio-Medical Waste Management
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kedar Jagirdar and Nihar Doctor serve as directors at the Company.
- CIN/LLPIN
U74900MH2014PTC257506
- Company No.
257506
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kalyan Bio-Medical Waste Management?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kedar Jagirdar  | Director | 29-Jul-2021 | Current |
| Nihar Doctor | Director | 23-Aug-2014 | Current |
Financial Performance of Kalyan Bio-Medical Waste Management.
Kalyan Bio-Medical Waste Management Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kalyan Bio-Medical Waste Management?
In 2017, Kalyan Bio-Medical Waste Management had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ecovision Environmental Resources LlpActive 9 years 10 monthsKedar Jagirdar and Nihar Doctor are mutual person
Enviro Circle Environmental Resources Ll PActive 5 years 9 monthsKedar Jagirdar and Nihar Doctor are mutual person
- Ecovision Environmental Resources (Vadod Ara) LlpActive 5 years 8 months
Kedar Jagirdar and Nihar Doctor are mutual person
- Eco Vision Environmental Resources (Ahem Dabad) LlpActive 4 years 10 months
Kedar Jagirdar and Nihar Doctor are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kalyan Bio-Medical Waste Management?
Unlock and access historical data on people associated with Kalyan Bio-Medical Waste Management, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kalyan Bio-Medical Waste Management, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalyan Bio-Medical Waste Management's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
